stage iii pancreatic cancer
Showing 26 - 50 of 61
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +7 more
-
La Jolla, California
- +13 more
Aug 30, 2018
Extrahepatic Bile Duct Cancer, Nausea, Vomiting Trial in Winston-Salem (drug, procedure, other)
Completed
- Extrahepatic Bile Duct Cancer
- +5 more
- aprepitant
- +8 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 16, 2018
Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Tumor, Resectable Pancreatic Cancer Trial in Cleveland (Irinotecan
Terminated
- Pancreatic Adenocarcinoma
- +8 more
- Irinotecan Hydrochloride
- +4 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 13, 2018
Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer Trial in United States (low intensity radiation therapy, Capecitabine,
Terminated
- Pancreatic Adenocarcinoma
- Stage III Pancreatic Cancer
- low intensity radiation therapy
- +4 more
-
Oakland, California
- +45 more
Jun 14, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Omaha (ADH-1,
Completed
- Ampulla of Vater Adenocarcinoma
- +19 more
- ADH-1
- +3 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jan 26, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +7 more
- dasatinib
- +5 more
-
Alhambra, California
- +16 more
Jan 5, 2018
Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel
Completed
- Adenocarcinoma of Unknown Primary
- +16 more
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- +4 more
-
Chicago, Illinois
- +7 more
Dec 8, 2017
Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)
Completed
- Adenocarcinoma of the Pancreas
- +5 more
- eribulin mesylate
-
Toronto, Ontario, CanadaUniversity Health Network-Princess Margaret Hospital
Sep 19, 2017
Patient Derived Cancer Cell Lines in Identifying Molecular
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Cytology Specimen Collection Procedure
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 5, 2017
Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (drug,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Rochester, MinnesotaMayo Clinic
Mar 21, 2017
Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Buffalo (Fluorouracil, Irinotecan
Withdrawn
- Colon Adenocarcinoma
- +16 more
- Fluorouracil
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 19, 2016
Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Duarte (Psychosocial Assessment
Completed
- Stage IIA Pancreatic Cancer
- +3 more
- Psychosocial Assessment and Care
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 1, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage I Pancreatic Cancer Trial (bevacizumab, gemcitabine HCl,
Withdrawn
- Adenocarcinoma of the Pancreas
- +4 more
- bevacizumab
- +11 more
- (no location specified)
Apr 27, 2015
Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B
Completed
- Recurrent Colon Cancer
- +13 more
- Detox-B adjuvant
- ras peptide cancer vaccine
-
Bethesda, MarylandMedicine Branch
Apr 27, 2015
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Buffalo (dovitinib
Withdrawn
- Duct Cell Adenocarcinoma of the Pancreas
- +4 more
- dovitinib lactate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 8, 2015
Intraductal Papillary Mucinous Tumor of the Pancreas, Recurrent Pancreatic Cancer, Stage IA Pancreatic Cancer Trial in Orange
Terminated
- Intraductal Papillary Mucinous Neoplasm of the Pancreas
- +6 more
- erlotinib hydrochloride
- +6 more
-
Orange, CaliforniaUniversity of California Medical Center At Irvine-Orange Campus
Oct 7, 2014
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (cetuximab, gemcitabine
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- cetuximab
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Apr 28, 2014
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Cleveland (sunitinib malate,
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- sunitinib malate
- gemcitabine hydrochloride
-
Cleveland, OhioCase Western Reserve University
Feb 21, 2014
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Hamilton, Toronto
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- gamma-secretase/Notch signalling pathway inhibitor RO4929097
- +3 more
-
Hamilton, Ontario, Canada
- +1 more
Feb 21, 2014
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2013
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Rochester (radiation therapy,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- radiation therapy
- +3 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Jul 15, 2013
Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Transitional Cell Cancer of
Terminated
- Advanced Adult Primary Liver Cancer
- +13 more
- gemcitabine hydrochloride
- +4 more
-
Boston, Massachusetts
- +2 more
Jul 1, 2013
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (sorafenib tosylate,
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- gemcitabine hydrochloride
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jul 1, 2013
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (drug, biological,
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- gemcitabine hydrochloride
- +5 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jun 4, 2013